DFP – Neuroprogressive and Dementia Network

Alzheimer’s Disease Research

The Deep & Frequent Phenotyping study (DFP) seeks to address the challenge of detecting Alzheimer’s disease before symptoms emerge by creating a comprehensive database of various measures from individuals at risk. This includes regular brain scans, cognitive and memory tests, retinal imaging, blood tests, and wearable technology assessments. Recruiting participants over 60 across sites in the UK, and is led by the University of Oxford. Our site is based in Edinburgh. By combining established and novel markers, DFP aims to identify the best indicators for early Alzheimer’s detection, ultimately enhancing the design and efficiency of future clinical trials. The study is supported by the MRC and NIHR, with findings accessible through the Dementias Platform UK Data Portal.

This study is in setup

To find out more about participating in our clinical trial research, please contact:
loth.sdcrn@nhs.scot
0131 537 3804

Key Staff

NDN Principle Investigator: Dr Catherine Pennington

NDN Study Lead: Marian Montanha

This is looking at patients with Alzheimer’s Disease and Healthy individuals.

CONTACT INFORMATION

Neuroprogressive & Dementia Research Network Office

Old Pharmacy Building
Western General Hospital
Edinburgh
EH4 2XU

Email: loth.sdcrn@nhs.scot

Telephone: 0131 537 3804

ABOUT US

The NRS Neuroprogressive Disease and Dementia Network team in NHS Lothian conduct commercial and investigator led studies for: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Motor Neurone Disease, dementia with Lewy bodies, Progressive Supranuclear Palsy and Multiple System Atrophy.